Among the companies with shares expected to actively trade in
Monday's session are Cognizant Techology Solutions Corp. (CTSH),
RadioShack Corp. (RSH) and Microsoft Corp. (MSFT).
Cognizant said Monday it agreed to buy closely held TriZetto
Corp. for $2.7 billion in cash, as it looks to capitalize on shifts
in health-care information technology driven by regulatory reform.
Shares rose 1.7% to $45.50 in premarket trading.
RadioShack appointed Holly F. Etlin as interim chief financial
officer, replacing John Feray, who resigned effective Friday. Mr.
Feray's departure is the latest in a series of executive changes as
the retailer faces a possible bankruptcy filing. Shares jumped
19.8% to $1.09 premarket.
Microsoft reached an agreement to acquire Mojang, the Swedish
company behind the popular "Minecraft" videogame, for $2.5 billion.
Shares were down slightly to $46.65 premarket.
Terex Corp. (TEX) lowered its full-year per-share earnings
outlook and provided third-quarter guidance that missed Wall
Street's views on weaker-than-expected demand in its cranes
business. Shares fell 8.5% to $31.75 premarket.
Bankrate Inc. (RATE) said Chief Financial Officer Edward DiMaria
"has resigned" and the company named Steven Barnhart as interim
CFO. The company also said the Securities and Exchange Commission
has begun an investigation related to its 2012 financial reporting.
Shares were inactive premarket.
Apple Inc. (AAPL) said Monday it had more than four million
preorders of its new iPhone 6 and iPhone 6 Plus in the first 24
hours, a figure the company dubbed a record. Shares gained 1.4% to
$103.05 premarket.
Gilead Sciences Inc. (GILD) said Monday it will allow generic
drug makers to make cheaper versions of its hepatitis C pill,
Sovaldi, to sell in developing countries. Indian drug makers
including Ranbaxy Laboratories Ltd. (5000359.BY) and Cipla Ltd.
(500087.BY), as well as Pennsylvania-based Mylan Inc. (MYL)
received licenses to produce Sovaldi. Gilead's shares fell 1.4% to
$102.17 premarket. Mylan's shares were up 2.1% to $48.06.
Danaher Corp. (DHR) agreed to buy Switzerland-based dental
implant maker Nobel Biocare Holding AG in a $2.2 billion cash deal.
Shares were inactive premarket.
Nucor Corp. (NUE) agreed to acquire Gallatin Steel Co. for about
$770 million.
Office Depot Inc. (ODP) said it will transfer its stock listing
to the Nasdaq Global Select Market from the New York Stock Exchange
later this month.
Avanir Pharmaceuticals Inc. (AVNR) announced positive results
from its Phase II clinical trial evaluating the safety and efficacy
of AVP-923 for the treatment of agitation in patients with
Alzheimer's disease.
Watchlist:
Seagate Technology Inc. (STX) raised its revenue expectations
for its fiscal first quarter on Friday as the data-storage company
experiences broad-based growth across all of its segments. Seagate
is now projecting revenue of $3.65 billion for the quarter, up from
the $3.55 billion it had previously expected.
NPS Pharmaceuticals Inc. (NPSP) said Friday a U.S. Food and Drug
Administration panel has recommended the company's experimental
hormone drug for approval, a key step in getting the drug approved
by the agency. The drug, Natpara, is used to treat
hypoparathyroidism.
More than half of the Boeing Co. (BA) machinists at the
company's St. Louis fighter-jet plant have signed up to take
voluntary buyouts, union leaders said Friday. The International
Association of Machinists and Aerospace Workers said 1,317 of its
2,300 members at the factory had registered with the company by a
July 31 deadline to take the voluntary buyout offer.
Cisco Systems Inc. (CSCO) said Marc Benioff, chairman and chief
executive of Salesforce.com Inc. (CRM), will step down from Cisco's
board of directors in November.
Barron's Watchlist:
As American Express Co. (AXP) expands its franchise, profits
could rise at a double-digit rate, lifting the stock nearly 30%,
according to an article in Barron's.
Write to Tom Rojas at tom.rojas@wsj.com and Josh Beckerman at
josh.beckerman@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires